Fighting COVID-19 at the Expense of Malaria in Africa: The Consequences and Policy Options

The American Journal of Tropical Medicine and Hygiene
Abdullahi Tunde AborodeFozia Farooq

Abstract

Malaria remains a major global health burden, killing hundreds of thousands annually, especially in sub-Saharan Africa. In December 2019, a novel illness termed COVID-19, caused by SARS-CoV-2, was reported in China. This disease soon spread around the world and was declared a pandemic by the WHO on March 11, 2020. Considering that the malaria burden is high in many low-income tropical countries with little capacity to fund malaria control and eradication programs, the fight against malaria in these regions is likely to be hindered by COVID-19. Indeed, access to health care has generally been limited during the pandemic, whereas malaria interventions, such as seasonal malaria chemoprevention, and distribution of long-lasting insecticide-treated bed nets, have been suspended because of lockdowns. Likewise, the repurposing of antimalarials for the treatment of COVID-19 and a shift in focus from the production of malaria rapid diagnostic tests to COVID-19 rapid diagnostic tests are causes for concern in malaria-endemic regions. COVID-19 has disproportionately affected developed countries, threatening their capacity to aid in malaria control efforts. Here, we address impacts of the COVID-19 pandemic on the management and control of ...Continue Reading

References

Jan 23, 2008·Genetical Research·Y B SaabA D J Overall
Dec 10, 2008·The New England Journal of Medicine·Harald NoedlUNKNOWN Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium
Jul 31, 2009·The New England Journal of Medicine·Arjen M DondorpNicholas J White
Feb 2, 2010·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Gunanidhi DhangadamajhiManoranjan Ranjit
Mar 3, 2011·PloS One·Victor Barbosa SaraivaAna Acacia de Sá Pinheiro
Apr 26, 2012·Malaria Journal·Justin M CohenBruno Moonen
Apr 30, 2015·The Lancet Infectious Diseases·Mary J Hamel, Laurence Slutsker
Jan 30, 2016·Genome Medicine·Naoko Hattori, Toshikazu Ushijima
Feb 18, 2016·Emerging Infectious Diseases·Alyssa S ParpiaAlison P Galvani
Dec 7, 2016·Malaria Journal·Sydney MwanzaMiriam Laufer
Apr 13, 2017·Malaria Journal·Temitope W AdemolueGordon A Awandare
May 1, 2019·The Lancet Infectious Diseases·Annie HaakenstadJoseph L Dieleman
May 11, 2020·American Journal of Obstetrics and Gynecology·Matthew J BlitzFrank A Chervenak
Jul 31, 2020·BMC Medicine·Stephen J RogersonUNKNOWN ACREME Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.